Trial No. Principal Investigator Trial Name
TRIO-US BMS CA209-627 "Basket" Accrual on hold Babu An open-label Phase 2 multi-cohort Trial of Nivolumab in advanced or metastatic malignancies. (CheckMate 627: Checkpoint pathway and Niolumab Clinical Trial Evaluation 627)
TRIO-US Medivation MDV3800-14 Babu A phase 1, open-label study to assess the effects of Talazoparib on cardiac repolarization in patients with advanced solid tumors
TRIO-US Medivation MDV3800-13 Open Label Expansion Babu A Single-Arm, Open-Label, Multicenter, Extended Treatment, Safety Study in Patients Treated With Talazoparib